These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35652295)

  • 41. (G)Patching up mis-splicing in cancer.
    Cieśla M; Bellodi C
    Trends Biochem Sci; 2024 Jul; 49(7):564-566. PubMed ID: 38762373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition.
    Sarchi M; Clough CA; Crosse EI; Kim J; Baquero Galvis LD; Aydinyan N; Wellington R; Yang F; Gallì A; Creamer JP; Stewart S; Bradley RK; Malcovati L; Doulatov S
    Blood Cancer Discov; 2024 Sep; 5(5):353-370. PubMed ID: 38856693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity.
    Kim Guisbert KS; Guisbert E
    PLoS One; 2017; 12(4):e0176382. PubMed ID: 28445500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.
    Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP
    Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spliceosome mutations in hematopoietic malignancies.
    Hahn CN; Scott HS
    Nat Genet; 2011 Dec; 44(1):9-10. PubMed ID: 22200771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splicing factor 3B1 hypomethylation is associated with altered SF3B1 transcript expression in older humans.
    Holly AC; Pilling LC; Hernandez D; Lee BP; Singleton A; Ferrucci L; Melzer D; Harries LW
    Mech Ageing Dev; 2014 Jan; 135():50-6. PubMed ID: 24463145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.
    Patnaik MM; Lasho TL; Finke CM; Hanson CA; Hodnefield JM; Knudson RA; Ketterling RP; Pardanani A; Tefferi A
    Am J Hematol; 2013 Mar; 88(3):201-6. PubMed ID: 23335386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
    Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
    Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pan-cancer analysis identifies mutations in
    Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SPF45/RBM17-dependent, but not U2AF-dependent, splicing in a distinct subset of human short introns.
    Fukumura K; Yoshimoto R; Sperotto L; Kang HS; Hirose T; Inoue K; Sattler M; Mayeda A
    Nat Commun; 2021 Aug; 12(1):4910. PubMed ID: 34389706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rare SF3B1 R625 mutations in cutaneous melanoma.
    Kong Y; Krauthammer M; Halaban R
    Melanoma Res; 2014 Aug; 24(4):332-4. PubMed ID: 24709888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
    Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
    Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. m
    Cieśla M; Ngoc PCT; Muthukumar S; Todisco G; Madej M; Fritz H; Dimitriou M; Incarnato D; Hellström-Lindberg E; Bellodi C
    Mol Cell; 2023 Apr; 83(7):1165-1179.e11. PubMed ID: 36944332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
    Papaemmanuil E; Cazzola M; Boultwood J; Malcovati L; Vyas P; Bowen D; Pellagatti A; Wainscoat JS; Hellstrom-Lindberg E; Gambacorti-Passerini C; Godfrey AL; Rapado I; Cvejic A; Rance R; McGee C; Ellis P; Mudie LJ; Stephens PJ; McLaren S; Massie CE; Tarpey PS; Varela I; Nik-Zainal S; Davies HR; Shlien A; Jones D; Raine K; Hinton J; Butler AP; Teague JW; Baxter EJ; Score J; Galli A; Della Porta MG; Travaglino E; Groves M; Tauro S; Munshi NC; Anderson KC; El-Naggar A; Fischer A; Mustonen V; Warren AJ; Cross NC; Green AR; Futreal PA; Stratton MR; Campbell PJ;
    N Engl J Med; 2011 Oct; 365(15):1384-95. PubMed ID: 21995386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional analysis of Hsh155/SF3b1 interactions with the U2 snRNA/branch site duplex.
    Carrocci TJ; Paulson JC; Hoskins AA
    RNA; 2018 Aug; 24(8):1028-1040. PubMed ID: 29752352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a high-resolution melting analysis for the detection of the SF3B1 mutations.
    Yang J; Qian J; Lin J; Yang XF; Qian W; Chen Q; Yao DM; Wang CZ; Chen XX; Xiao GF; Ma YJ
    Genet Test Mol Biomarkers; 2013 Apr; 17(4):342-7. PubMed ID: 23390883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer.
    Zhang J; Huang J; Xu K; Xing P; Huang Y; Liu Z; Tong L; Manley JL
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2216712119. PubMed ID: 36459648
    [No Abstract]   [Full Text] [Related]  

  • 58. Disclosing the Impact of Carcinogenic SF3b Mutations on Pre-mRNA Recognition Via All-Atom Simulations.
    Borišek J; Saltalamacchia A; Gallì A; Palermo G; Molteni E; Malcovati L; Magistrato A
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31640290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition.
    Chaudhry S; Beckedorff F; Jasdanwala SS; Totiger TM; Affer M; Lawal AE; Montoya S; Tamiro F; Tonini O; Chirino A; Adams A; Sondhi AK; Noudali S; Cornista AM; Nicholls M; Afaghani J; Robayo P; Bilbao D; Nimer SD; Rodríguez JA; Bhatt S; Wang E; Taylor J
    Leukemia; 2024 Sep; 38(9):1894-1905. PubMed ID: 38997434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemia.
    Yang J; Qian J; Yao DM; Qian SX; Qian W; Lin J; Xiao GF; Wang CZ; Deng ZQ; Ma JC; Chen XX
    Clin Biochem; 2013 May; 46(7-8):701-3. PubMed ID: 23395771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.